Eli Lilly and Company
METHODS OF TREATING PSORIASIS
Last updated:
Abstract:
The present invention generally relates to the treatment of psoriasis with an antibody that binds to the p19 subunit of human IL-23, in particular dosage regimens for the treatment of the disease.
Status:
Application
Type:
Utility
Filling date:
5 Sep 2019
Issue date:
3 Mar 2022